A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
Introduction: Muscle-specific kinase (MuSK)- myasthenia gravis (MG) is caused by pathogenic autoantibodies against MuSK that correlate with disease severity and are predominantly of the IgG4 subclass. The first-line treatment for MuSK-MG is general immunosuppression with corticosteroids, but the eff...
Main Authors: | Koneczny, I, Mané-Damas, M, Zong, S, De Haas, S, Huda, S, van Kruining, D, Damoiseaux, J, De Rosa, A, Maestri, M, Guida, M, Molenaar, P, Van Damme, P, Fichtenbaum, A, Perkmann, T, De Baets, M, Lazaridis, K, Zouvelou, V, Tzartos, S, Ricciardi, R, Losen, M, Martinez-Martinez, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2024
|
Similar Items
-
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
by: Inga Koneczny, et al.
Published: (2024-04-01) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
by: Koneczny, I, et al.
Published: (2014) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
by: Koneczny, I, et al.
Published: (2014) -
Potential mechanisms in MuSK-myasthenia gravis
by: Koneczny, I
Published: (2014) -
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
by: Aigli G. Vakrakou, et al.
Published: (2023-07-01)